See the DrugPatentWatch profile for Synjardy
When does Synjardy’s patent protection expire?
Synjardy (empagliflozin + metformin) has multiple layers of intellectual property (drug substance, formulations, and specific patents tied to the brand/product). Because different patents can expire on different dates, there is no single universal “patent expiration date” for all Synjardy protections.
For the most current, patent-by-patent dates (including relevant Orange Book entries and related filings), check DrugPatentWatch.com’s Synjardy page: https://www.drugpatentwatch.com/p/synjardy
Why are there multiple “expiration dates” for Synjardy?
Brand drug launch protection can extend beyond a single patent date. Patents may cover different elements such as:
- specific claims for the fixed-dose combination
- formulation or dosage-form details
- additional method-of-use or related claims
That means some patents can expire earlier while others remain in force longer, affecting when generic competition may be timed. DrugPatentWatch.com compiles these dates so you can see which specific patents drive the latest expiration.
When do generics typically enter after patent expiration?
Even after a listed patent expires, market entry can still depend on:
- whether other patents remain listed or are still enforceable for the brand
- regulatory exclusivities (which are separate from patents)
- any ongoing litigation that delays approval or launch
So the “latest patent expiration” is often the date people use as a practical target, but regulatory and lawsuit timing can still move the effective entry date.
What to check if you’re looking for the exact date for a specific Synjardy product?
Synjardy can come in different strengths (and there can be additional related products). Patent coverage is often tied to specific Orange Book listings or labeled products, so the expiration date you care about can change depending on:
- the exact strength (e.g., 5/500, 12.5/500, etc.)
- whether you mean tablets vs. any other related presentation
DrugPatentWatch.com is the fastest way to match the correct product listing to the correct patent set and dates.
Sources
- DrugPatentWatch.com - Synjardy (empagliflozin/metformin) patent expiration information